Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY
Idiopathic pulmonary fibrosis has a poor prognosis with limited treatment options. The Investigator hypothesize hyperpolarized Xe129-MRI can be performed in patients with IPF and repeated over time which will detect deficiencies related to perfusion in the lung.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Able to provide informed consent 18 years of age or greater Clinical diagnosis of IPF
Locations
United States
Virginia
Snyder Building 480 Ray C. Hunt Drive
RECRUITING
Charlottesville
Contact Information
Primary
Roselove Asare, MA
rnn3b@uvahealth.org
4342436074
Backup
Carol Bampoe, BS
Time Frame
Start Date: 2025-05-01
Estimated Completion Date: 2027-12
Participants
Target number of participants: 6
Treatments
Other: IPF subjects
IPF subjects will undergo Xe-129 MRI
Related Therapeutic Areas
Sponsors
Leads: University of Virginia